Response to: Identifying optimal first-line treatment for advanced non-small cell lung carcinoma with high PD-L1 expression: a matter of debate.
Yimin WangHedong HanFang ZhangTangfeng LvPing ZhanMingxiang YeYong SongHongbing LiuPublished in: British journal of cancer (2022)